Target Range of Zwittermicin A, an Aminopolyol Antibiotic from Bacillus cereus

Zwittermicin A is a novel antibiotic produced by Bacillus cereus UW85, which suppresses certain plant diseases in the laboratory and in the field. We developed a rapid method for large-scale purification of zwittermicin A and then studied the in vitro activity of zwittermicin A against bacteria, fungi, and protists. Zwittermicin A was highly active against the Oomycetes and their relatives, the algal protists, and had moderate activity against diverse Gram-negative bacteria and certain Gram-positive bacteria as well as against a wide range of plant pathogenic fungi. Zwittermicin A was more active against bacteria and fungi at pH 7–8 than at pH 5–6. When zwittermicin A was combined with kanosamine, another antibiotic produced by B. cereus, the two acted synergistically against Escherichia coli and additively against Phytophthora medicaginis, an Oomycete. The results indicate that there are diverse potential applications of this new class of antibiotic. Received: 1 December 1997 / Accepted: 9 January 1998     

The antimicrobial activity of the mandibular gland secretion of a formicine ant, Calomyrmex sp. (Hymenoptera: Formicidae)

The mandibular gland secretion from mature workers of the formicine ant Calomyrmex sp. exhibits strong antimicrobial activity when tested against selected soil microorganisms. The activity against bacteria is both inhibitory and bacteriocidal while that against fungi is inhibitory. The white secretion from young workers appears to be much weaker in its antibiotic effects.     

Fungicidal effect of prenylated flavonol, papyriflavonol A, isolated from Broussonetia papyrifera (L.) vent. against Candida albicans

Papyriflavonol A (PapA), a prenylated flavonoid (5,7,3',4'-tetrahydroxy-6,5'-di-(r,r-dimethylallyl)-flavonol), was isolated from the root barks of Broussonetia papyriferra. Our previous study showed that PapA has a broad-spectrum antimicrobial activity against pathogenic bacteria and fungi. In this study, the mode of action of PapA against Candida albicans was investigated to evaluate PapA as antifungal agent. The minimal inhibitory concentration (MIC) values were 10~25 microgram/ml for C. albicans and Saccharomyces cerevisiae, gram-negative bacteria (Escherichia coli and Salmonella typhimurium) and gram-positive bacteria (Staphylococcus epidermidis and Staphylococcus aureus). The kinetics of cell growth inhibition, scanning electron microscopy, and measurement of plasma membrane florescence anisotrophy revealed that the antifungal activity of PapA against C. albicans and S. cerevisiae is mediated by its ability to disrupt the cell membrane integrity. Compared with amphotericin B, a cell membrane disrupting polyene antibiotic, the hemolytic toxicity of PapA was negligible. At 10~25 microgram/ml of MIC levels for the tested strains, the hemolysis ratio of human erythrocytes was less than 5%. Our results suggest that PapA could be a therapeutic fungicidal agent having a broad spectrum antimicrobial agent.     

JU-2, a novel phosphorous-containing antifungal antibiotic from Streptomyces kanamyceticus M8

A novel phosphorous-containing antifungal antibiotic JU-2 was isolated from Streptomyces kanamyceticus M8. Quantitative chemical analysis shows the presence of two phenylalanines, two glucose, one linoleic acid, one crucic acid and one phosphonamide moiety per molcule of the antibiotic. JU-2 shows strong inhibitory activity against various pathogenic and non-pathogenic fungi but no activity against bacteria and yeast.     

Purification and characterization of an antibiotic substance produced from Rhizopus oligosporus IFO 8631.

We obtained a purified antibiotic protein from the submerged cultivation broth of Rhizopus oligosporus IFO 8631 by using CM-Cellulofine chromatography and HPLC. The antibiotic did not show a broad spectrum of activity, but it was very active against some of the Bacillus species, especially against Bacillus subtillis (B. natto) at a very low concentration (less than 1 ppm). It also showed activity against other gram-positive bacteria, including Staphylococcus aureus and Streptococcus cremoris. The purified antibiotic was a simple protein of about 5,500 in molecular weight, the amino acid component being characteristically high in cystine content. This high cystine content contributed to the stability of the antibiotic over a wide pH range and against strong heating (50% of the activity remained after boiling for 1 hr).     

Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.

The alpha-helical antibiotic peptide (P18: KWKLFKKIPKFLHLAKKF-NH2) designed from the cecropin A(1-8)-magainin 2 (1-12) hybrid displayed strong bactericidal and tumoricidal activity without inducing hemolysis. The effect of the Pro9 residue at central position of P18 on cell selectivity was investigated by Pro9 --> Leu or Pro9 --> Ser substitution. Either substitution markedly reduced the antibacterial activity of P18 and increased hemolysis, although it did not significantly affect cytotoxicity against human transformed tumor and normal fibroblast cells. These results suggest that a proline kink in alpha-helical antibiotic peptide P18 serves as a hinge region to facilitate ion channel formation on bacterial cell membranes and thus plays an important role in providing high selectivity against bacterial cells. Furthermore, to investigate the structure-antibiotic activity relationships of P18, a series of N- or C-terminal deletion and substitution analogs of P18 were synthesized. The C-terminal region of P18 was related to its antibiotic activity and alpha-helical conformation on lipid membranes rather than N-terminal one. Higher alpha-helicity of the peptides was involved in the hemolytic and antitumor activity rather than antibacterial activity. Except for [L9]-P18 and [S9]-P18, all the designed peptides containing a Pro residue showed potent antibacterial activity, although they did not induce a cytolytic effect against human erythrocyte and normal fibroblast cells at the concentration required to kill bacteria. In particular, P18 and some analogs (N-1, N-2, N-3, N-3L and N-4L) with potent bactericidal and tumoricidal activity and little or no normal cell toxicity may serve as an attractive candidate for the development of novel anti-infective or antitumor agents.     

Ceftazidime, a broad spectrum cephalosporin with activity against Ps. aeruginosa

Ceftazidime is one of the oximinoaminothiazolyl cephalosporins with resistance to most B-lactamases from gram-negative bacteria, and a very wide spectrum of activity including Ps. aeruginosa. MIC's of less than 0.1 mg/l are seen routinely against E. coli, K. pneumoniae, E. cloacae, Proteus spp. both indole positive and negative, Serratia sp., and Providence sp. The mean MIC against clinical isolates of Ps. aeruginosa is less than 2 mg/l. It is bactericidal at concentrations close to the MIC and its activity is unimpaired in the presence of serum. Ceftazidime is well distributed in the body, penetrating into all body fluids at concentrations excess of the MIC's of most pathogenic bacteria. It has a half-life of about 1.5 hours, is excreted almost exclusively by the kidney and is not bound to serum proteins. More than 12,000 patients have now been treated with the antibiotic, with an overall success rate of more than 93%.     

Solution structure of a cathelicidin-derived antimicrobial peptide, CRAMP as determined by NMR spectroscopy.

CRAMP was identified from a cDNA clone derived from mouse femoral marrow cells as a member of cathelicidin-derived antimicrobial peptides. This peptide shows potent antimicrobial activity against gram-positive and gram-negative bacteria but no hemolytic activity against human erythrocytes. CRAMP was known to cause rapid permeabilization of the inner membrane of Escherichia coli. In this study, the structure of CRAMP in TFE/H2O (1 : 1, v/v) solution was determined by CD and NMR spectroscopy. CD spectra showed that CRAMP adopts a mainly alpha-helical conformation in TFE/H2O solution, DPC micelles, SDS micelles and liposomes, whereas it has a random structure in aqueous solution. The tertiary structure of CRAMP in TFE/H2O (1 : 1, v/v), as determined by NMR spectroscopy, consists of two amphipathic alpha-helices from Leu4 to Lys10 and from Gly16 to Leu33. These two helices are connected by a flexible region from Gly11 to Gly16. Previous analysis of series of fragments composed of various portion of CRAMP revealed that an 18-residue fragment with the sequence from Gly16 to Leu33 was found to retain antibacterial activity. Therefore, the amphipathic alpha-helical region from Gly16 to Leu33 of CRAMP plays important roles in spanning the lipid bilayers as well as its antibiotic activity. Based on this structure, novel antibiotic peptides having strong antibiotic activity, with no hemolytic effect will be developed.     

U-21,963, a New Antibiotic: I. Discovery and Biological Activity

A new antibiotic, U-21,963, is produced by a new strain of Trichoderma viride. Antibiotic activity can be demonstrated against both gram-positive and gram-negative bacteria and also against a wide variety of fungi. U-21,963 is not cross-resistant with other commonly used antibiotics. U-21,963 afforded no protection against Klebsiella pneumoniae, Streptococcus pyogenes, or Staphylococcus aureus when it was injected subcutaneously into mice.     

骏枣内生生防细菌的分离、筛选与鉴定

选择交城骏枣(Zizyphus jujube cv.Jiaocheng Junzao)作为分离内生细菌的材料,从中共分离到18株内生菌株,运用平板对峙法从中筛选出5株对大枣病原菌及部分植物病原菌有拮抗作用的内生细菌。抑菌试验结果表明:筛选出的5株细菌对刺盘胞菌Colletotrichum gloeosporides、链格孢菌Alternaria alternata、尖孢镰刀菌Fusarium oxysporium、烟草赤星病菌Alternarial longipes、稻瘟病菌Pyricularia oryzae、人参立枯病菌Rhizoctonia solani、人参菌核病菌Sclerotinia schinseng和小麦根腐病菌Bipolaris sorokiniana均有一定的抑菌活性。对这5株内生细菌进行了形态特征观察和生理生化鉴定。     

The Semi Large-scale Production, Extraction, Purification and Properties of an Antibiotic Produced by Bacillus licheniformis Strain 2725

S ummary : Production, extraction, purification and properties of an antibiotic produced by Bacillus liclieniformis , strain 2725 are described. Extraction efficiency was c. 50% with 8–10 g of product/350 1 batch culture, the product having an activity of 2000 units/mg (0·5 μg/ml) against Staphylococcus aureus Paler. The antibiotic was a peptide, was active against Gram positive and negative bacteria; it was stable over a wide pH range, its bactericidal activity was enhanced by serum, but it had a high toxicity and was haemolytic.     

MYCOBACTOCIDIN, A NEW ANTIBIOTIC ACTIVE AGAINST MYCOBACTERIA.

Fregnan, G. B. (University of Wisconsin, Madison) and D. W. Smith. Mycobactocidin, a new antiboitic active against mycobacteria. J. Bacteriol. 83:1069-1076. 1962.-A new antibiotic, produced by a strain of Staphylococcus epidermidis, is described. The name mycobactocidin is proposed because of the specificity of the antibiotic against mycobacteria. Methods for extraction and purification of the antibiotic are described. The water-soluble fraction is shown to be active in vitro. No toxicity could be detected in mice after intraperitoneal or subcutaneous injection. Enzymatic hydrolysis suggests a glyco-protein nature for the antibiotic. Mycobactocidin is soluble in distilled water at neutrality but is generally insoluble in organic solvents. The antibiotic is precipitated from aqueous solution by heavy metals. It is stable in the pH range of 2 to 8, but is precipitated at pH 3 to 4. An aqueous solution of the antibiotic is stable for several days at 5 C, and for longer periods if lyophilized and stored at -20 C. It does not pass through a dialysis membrane and its activity is retained after 15 to 20 hr of dialysis at 5 C. The activity was shown to be unrelated to the formation of hydrogen peroxide.     

Purification and characterization of enterocin 4, a bacteriocin produced by Enterococcus faecalis INIA 4.

A simple two-step procedure was developed to obtain pure enterocin 4, a bacteriocin produced by Enterococcus faecalis INIA 4. Chemical and genetic characterization revealed that the primary structure of enterocin 4 is identical to that of peptide antibiotic AS-48 from Enterococcus faecalis S-48. In contrast to the reported inhibitory spectrum of AS-48, enterocin 4 displayed no activity against gram-negative bacteria.     

Antibacterial activity of ethanolic and aqueous extracts of Acacia aroma Gill. ex Hook et Arn

The purpose of the present study was to investigate the antibacterial activity of seven ethanolic extracts and three aqueous extracts from various parts (leaves, stems and flowers) of A. aroma against 163 strains of antibiotic multi-resistant bacteria. The disc diffusion assay was performed to evaluate antibacterial activity of the A. aroma crude extracts, against several Gram-positive bacteria (E. faecalis, S. aureus, coagulase-negative stahylococci, S. pyogenes, S. agalactiae, S. aureus ATCC 29213, E. faecalis ATCC 29212) and Gram-negative bacteria (E. coli., K. pneumoniae, P. mirabilis, E. cloacae, S. marcescens, M morganii, A. baumannii, P. aeruginosa, S. maltophilia, E. coli ATCC 35218, P. aeruginosa ATCC 27853, E. coli ATCC 25922). All ethanolic extracts showed activity against gram-positive bacteria. Among all obtained extracts, only leaf and flower fluid extracts showed activity against Gram-negative bacteria. Based on this bioassay, leaf fluid extracts tended to be the most potent, followed by flower fluid extracts. Minimal inhibitory concentration (MIC) values of extracts and antibiotics were comparatively determined by agar and broth dilution methods. Both extracts were active against S. aureus, coagulase-negative stahylococci, E. faecalis and E. faecium and all tested Gram-negative bacteria with MIC values from 0.067 to 0.308 mg/ml. In this study the minimal bactericidal concentration (MBC) values were identical or twice as high than the corresponding MIC for leaf extracts and four or eight times higher than MIC values for flower extracts. This may indicate a bactericidal effect. Stored extracts have similar antibacterial activity as recently obtained extracts. The A. aroma extracts of leaves and flowers may be useful as antibacterial agents against Gram- negative and Gram-positive antibiotic multi-resistant microorganisms.     

Salt resistance and synergistic effect with vancomycin of alpha-helical antimicrobial peptide P18.

P18 (KWKLFKKIPKFLHLAKKF-NH(2)) is an alpha-helical antimicrobial peptide designed from a cecropin A-magainin 2 hybrid. In this study, P18 was found to show strong antimicrobial activity against several antibiotic-resistant bacterial and fungal strains. Both the salt resistance on antimicrobial activity and the synergistic effect with clinically used antibiotic agents are critical factors in developing effective peptide antibiotic drugs. For this reason, we investigated the salt resistance of P18 to antagonism by NaCl, CaCl(2), and MgCl(2) on antimicrobial activity and the synergistic effect of P18 with vancomycin against vancomycin-resistant Enterococcus faecium (VREF). Compared to magainin 2, P18 showed strong resistance on antimicrobial activity against bacterial strains and C. albicans under high NaCl concentrations of 100-200 mM. In addition, P18 displayed much greater salt resistance on antibacterial activity against Gram-negative bacteria at the physiological or elevated concentrations of CaCl(2) and MgCl(2) than magainin 2. Furthermore, the combination study revealed that P18 has a relatively effective synergistic effect with vancomycin against VREF. Thus, these results support that P18 may prove to be a salt-resistant antibiotic peptide potentially useful in the treatment of cystic fibrosis patients as well as a valuable adjuvant for antimicrobial chemotherapy.     

真菌防御素plectasin研究进展

抗生素耐受现象日益严重,迫切需要研发新型抗菌药物。Plectasin是第一例报道的真菌防御素,其抗菌谱窄,仅对革兰氏阳性菌具有强大的杀菌活性,对其进行结构改造可进一步提高其抗菌作用特异性。Plectasin抗菌机制明晰,作用于细胞壁合成。其药物代谢动力学研究较为透彻,同时可在体外高产量表达且活性更高。这些研究为其应用提供了理论基础。综上,plectasin具有极大的临床应用潜力。     

Antibiotic Complex SP-351 Produced by a Psychrophile,Streptomyces sp. No. 351

In the course of a screening study for antibiotics using psychrophilic microorganisms a water-insoluble antibiotic complex, SP–351, was found in the culture filtrate of a psychrophilic actinomycete, strain No. 351. This active principle was isolated and characterized as a cyclicpolylactone antibiotic. The SP–351-producing strain was classified as a facultative psychrophile and identified as Streptomyces phaeochromogenes.

The main components of the antibiotic complex SP–351 changed with the composition of the culture medium but not with culture temperatures. Component A was exclusively produced in a medium composed of roasted soybean powder and glycerol; components B and C in a medium composed of soybean, glycerol and potassium nitrate; and components A and D in a synthetic medium containing a hydrocarbon, alcohol or ester as the sole carbon source. Maximum production of SP–351 from n-paraffin and methyl acetate was 10 and 15 mcg/ml, respectively.

SP–351 showed strong antibacterial activity against Gram-positive bacteria and acid-fast bacteria at 0.1~0.3 mcg/ml concentrations.     

Biological activity of an antibiotic produced by Myxococcus coralloides.

A strain of Myxococcus coralloides was isolated which produced an antibiotic active against Gram-positive bacteria and also against Neisseria sp at high levels of antibiotic. The antibiotic was bactericidal on sensitive growing bacteria. It was inactive on non-growing cells and also on cells whose growth has been stopped by addition of chloramphenicol. Strains of S. aureus resistant to several antibiotics, including penicillin and ampicillin, were also sensitive to this antibiotic.     

A new antifungal antibiotic produced byStreptomyces galbus

A streptomycete producing an antibiotic having antifungal and antibacterial activity was isolated from a soil sample of West Bengal. It was characterized and identified as Streptomyces galbus. The antibiotic was isolated from the fermented broth by treatment with activated charcoal and purified by chromatography on alumina and paper. It is a colourless, odourless, hygroscopic, amorphous compound. Although homogeneous by paper and thin-layer chromatography, the possibility of the presence of two components was indicated by gel filtration. Its physico-chemical characteristics and UV-absorption spectrum suggest a non-polyenic nature. It is active against a wide variety of fungi and bacteria. It has some phytotoxic effect, but is relatively non-toxic to rats.     

Antibiotic Production by Anaerobic Bacteria

Soils from aerobic and anaerobic sources were investigated for the possible presence of bacteria which produce antibiotics under anaerobic conditions of growth. The screening techniques devised for this study yielded 157 soil bacteria which, during anaerobic growth, produced antibiotic activity against aerobic test bacteria.

Studies on choice of media, presence of oxygen, and changes in antibiotic activity during growth indicated that representative strains of these bacteria produced mixtures of antibiotics. The activity was heat labile.